abstract |
FIELD: biotechnology.SUBSTANCE: invention relates to a conjugate which specifically binds an extracellular domain epitope PLVAP, and can be used in medicine.EFFECT: obtained conjugate can be used to create a drug for effective therapy of hepatocellular carcinoma (HHC) with PLVAP-positive vascular system.22 cl, 2 tbl, 1 ex, 24 dwg |